Vivus Inc (VVUS) $26.20 +0.31%
Vivus Pharmaceuticals (VVUS) is up a nickel to $26.17 and more than 6,400 Sep 23 puts have traded on the biotech today on ISE. Customers are buying to open, according to ISEE data. 8,300 Sep 23 puts on VVUS now traded across all the exchanges. Total volume on the stock is 13,000 puts and 4,100 calls. 30-day ATM vols are up 10 percent and elevated at 149. Bearish trading in VVUS might be a play on Arena’s June 27 PDUFA date for obesity drug lorcaserin and the company’s own Jul 17 PDUFA for Qnexa.
Category: All Stocks, Pharmaceuticals & Biotechnology, Small Cap Stocks
Free Newsletter
If you enjoyed this article, sign up to receive more just like it.
About the Author (Author Profile)
Frederic Ruffy is a well-known trader, writer, and strategist who has spent years educating investors and creating intelligent, insightful, unbiased market observations that are frequently cited by the Wall Street Journal and other financial publications. As senior analyst, Fred provides frequent and regular notes and daily updates for activity of interest.
